Jennie H. Kwon, DO, MSCI, assistant professor, ID fellow ’16, has been elected to serve as the chair of the Bureau of Emerging Leaders and the New Physician in Practice member of the AOA Board of Trustees. Dr. Kwon is an assistant professor of medicine and a board certified internist and infectious diseases specialist at the Washington University School of Medicine in St. Louis. She is also an associate hospital epidemiologist at Barnes-Jewish Hospital in St. Louis. Dr. Kwon is the 2016-2018 National Academy of Medicine (formally the Institute of Medicine) Anniversary Fellow in Osteopathic Medicine and is actively working with the academy’s expert committees to research important questions relevant to public health and health policy.
In the clinical setting, Dr. Kwon provides in-and out-patient care to patients with solid organ and bone marrow transplant related infections. Dr. Kwon performs clinical and translational research in multidrug-resistant organisms and the impact of antimicrobials on the fecal microbiome. Her research has been funded by the Centers for Disease Control and Prevention, and the National Institutes of Health.
Dr. Kwon has been an active member of the American Osteopathic Association since starting medical school, and is committed to advancing public health and the osteopathic profession. Her experiences as a clinician, scientist, and leader have prepared her to advance the philosophy, science, and practice of osteopathic medicine.
Recently, Jennie also received other national positions. She was selected member of the SHEA Research Network Review Committee for a three year term. SHEA fosters opportunities to conduct, sponsor, and promote high-quality research through the leadership of the SHEA Research Committee and the collaborative infrastructure provided by the SHEA Research Network (SRN). As a community of researchers, the committee and SRN work to highlight priority topics and address challenges in the elimination of HAIs.
Jennie was also appointed to a 1 year term on the IDSA’s Research Committee Advisory Group. This committee serves to make recommendations to promote research and new advancements in infectious diseases. Members also monitor developments and make recommendations related to federal support for biomedical research and make recommendations on activities/issues under its purview that involve federal legislation and regulation.